does tirzepatide raise resting heart rate and Rate: What to Know Does Tirzepatide Raise Heart Rate?

A recent meta-analysis demonstrated that PPI use increased infection rate by 75% (Willems et al., 2020), including infections by multidrug-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus

In 2024, the FDA approved Wegovy to reduce heart-related risks in people with cardiovascular disease who meet the criteria for overweight or obesity

The findings showed that Semaglutide was effective in promoting weight loss without the risk of hypoglycemia, making it a promising option for non-diabetic individuals seeking to manage their weight

The oral Wegovy pill allows daily dosage for those who wish to avoid injections

Adequate magnesium levels help keep NMDA receptors in check, potentially raising the threshold for central sensitization

The MHRA and EMA continue post-marketing surveillance with no specific warnings linking tirzepatide to bowel cancer issued to date